Drugs / marrow stromal cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00908856 Comparator | Jan 2016 → Dec 2017 | stroke disorder | University of California, Irvine | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | marrow stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00908856 ↗ |
| Route | Intravenous | “a single intravenous transfusion approximately 21 days after bone marrow aspiration, and 23 days after stroke onset” NCT00908856 ↗ |